Chronic and Acute Leukemias in Adults

Chronic and Acute Leukemias in Adults edited by Clara D. Bloomfield.

Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general on­ cology textbooks are generally out of date. Single papers in specialized jour­ nals are informative but seldom comprehensive; these are more often pre­ limina...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Bloomfield, Clara D. (Editor)
Format: eBook
Language:English
Published: New York, NY : Springer US : Imprint: Springer, 1985.
Edition:1st ed. 1985.
Series:Cancer Treatment and Research, 26
Springer eBook Collection.
Subjects:
Oncology  .
Electronic resources (E-books)
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • 1. Retroviruses and Onc Genes in Human Leukemias and Lymphomas
  • 1.1 Introduction
  • 1.2 Onc Genes in Leukemogenesis
  • 1.3 Retroviruses in Human Leukemia-Lymphoma
  • 2. Study of Differentiation and Proliferation of Leukemic Cells Using Myeloid Leukemia Cell Lines
  • 2.1 Introduction: Establishment of Human Myeloid Leukemia Cell Lines
  • 2.2 Human Erythroleukemia Cell Lines
  • 2.3 Study of Granulocyte Differentiation Using Myeloid Leukemic Cell Lines
  • 2.4 Induction of Macrophage-Like Differentiation of Human Acute Myelogenous Cells
  • 2.5 Genetic Analysis of Myeloid Differentiation
  • 2.6 Hormonal Modulation of Leukemic Cell Growth
  • 2.7 An In Vitro Model for Chemotherapy of Acute Myelogenous Leukemia
  • 2.8 Conclusion
  • Acknowledgements
  • References
  • 3. Biological Markers in Lymphoproliferative Disorders
  • 3.1 Introduction
  • 3.2 Immunological Markers
  • 3.3 Chronic B-Cell Malignancies
  • 3.4 Chronic T-Cell Malignancies
  • 3.5 Cytochemistry of Acid Hydrolases
  • 3.6 Chromosomes
  • 3.7 Conclusions
  • Acknowledgements
  • References
  • 4. Surface Marker Analysis of Acute Myeloblasts Leukemia
  • 4.1 Introduction
  • 4.2 Differentiation of Normal Myeloid Cells
  • 4.3 Detection of Myeloid-Lineage Antigens by Heteroantisera
  • 4.4 Production of Monoclonal Antibodies to Myeloid Cell Surface Antigens
  • 4.5 Monoclonal Antibodies Reactive with Human AML Cells
  • 4.6 Expression of Myeloid Differentiation Antigens on AML Cells
  • 4.7 Future Directions
  • References
  • 5. Classification of 358 Cases of Acute Myeloid Leukemia by FAB Criteria: Analysis of Clinical and Morphologic Features
  • 5.1 Introduction
  • 5.2 Clinical and Morphologic Characteristics of the FAB Classes
  • 5.3 Comparison of FAB Classes of AML
  • 5.4 Discussion
  • References
  • 6. Chemosensitivity of In Vitro Colony Forming Units as a Predictor of Response to Antileukemic Drugs
  • 6.1 Introduction
  • 6.2 Colony Assays
  • 6.3 Quantitation of Sensitivity to Antileukemic Drugs
  • 6.4 Correlations Between In Vitro Chemosensitivities of L-CFU and Clinical Response of the Patient
  • 6.5 Summary
  • References
  • 7. Post-Remission Therapy for Acute Myelogenous Leukemia
  • 7.1 Introduction
  • 7.2 Role of Induction Therapy on Remission Duration
  • 7.3 Role of Consolidation Therapy on Remission Duration
  • 7.4 Role of Maintenance Chemotherapy in Prolonging Remissions
  • 7.5 The Role of Immunotherapy in Maintenance
  • 7.6 Prognostic Variables Predicting for Prolonged Remission Duration
  • 7.7 Central Nervous System Leukemia
  • 7.8 Bone Marrow Transplantation
  • 7.9 Summary and Conclusions
  • Acknowledgement
  • References
  • 8. The Role of Marrow Transplantation in the Treatment of Leukemia
  • 8.1 Introduction
  • 8.2 Donor Selection
  • 8.3 Preparative Regimens
  • 8.4 Techniques of Marrow Transplantation
  • 8.5 Clinical Results in Acute Nonlymphoblastic Leukemia (ANL)
  • 8.6 Clinical Results in Acute Lymphoblastic Leukemia (ALL)
  • 8.7 Clinical Results in Chronic Granulocytic Leukemia (CGL)
  • 8.8 Leukemic Recurrence After Transplantation
  • 8.9 Graft-Versus-Host Disease (GVHD)
  • 8.10 Infectious Complications, Including Interstitial Pneumonia
  • 8.11 Other Organ Toxicities
  • 8.12 Summary
  • Acknowledgements
  • References
  • 9 Hyperleukemias in Adult Leukemia
  • 9.1 Introduction
  • 9.2 Acute Myelocytic Leukemia
  • 9.3 Chronic Myelocytic Leukemia
  • 9.4 Acute Lymphocytic Leukemia
  • 10 New Developments in the Etiology, Diagnosis, Treatment and Prevention of Infectious Complications in Patients with Leukemia
  • 10.1 Introduction
  • 10.2 Changing Patterns of Infections
  • 10.3 New Developments in Evaluation and Diagnosis
  • 10.4 Developments in Antimicrobial Therapy
  • 10.5 New or Evolving Syndromes in Management of Infections in the Adult Leukemic
  • 10.6 Recent Developments in Adjuvant Therapy
  • 10.7 Current Concepts in Infection Prevention in Acute Leukemia.

Similar Items